The five Danish Steno Diabetes Centers have been established in a public-private partnership between the Danish healthcare system and the Novo Nordisk Foundation. The Novo Nordisk Foundation has awarded a grant to modernize and systematize the current healthcare options for people with diabetes. The grant covers treatment, research, education and cross-sector collaboration as well as new buildings. Steno Diabetes Center Copenhagen was established as the first centre on 1 January 2017. The other Danish centres were established in 2018 and 2019.
Establishment of five Danish Steno Diabetes Centers
DKK 2.8 billion for new diabetes centre in Copenhagen
The Novo Nordisk Foundation is making this plan possible by a grant of up to DKK 2.8 billion (€375 million) from now until 2029. The grant is the Foundation’s largest single award to date. “We have…
Novo Nordisk Foundation approves a vision statement for Steno Diabetes Center North Denmark
“We are pleased that agreement has been reached on a framework for a vision for diabetes initiatives in the North Denmark Region. The Foundation’s goal is that this new measure will improve treatment, research and…
Novo Nordisk Foundation awards DKK 2.8 billion to strengthen diabetes initiatives in Denmark
On 5 September 2017, the Board of Directors of the Novo Nordisk Foundation approved grants of DKK 1.4 billion to the Region of Southern Denmark and DKK 1.4 billion to the Central Denmark Region to…